Atlas Trials

TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

Clinical trial NCT05555316 · UNKNOWN

Trial details

NCT number
NCT05555316
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Tumor
Start date
2019-11-10
Primary completion
2023-01-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.